It's a crazy world, ab. If SPL had selected McKesson to...

It's a crazy world, ab. If SPL had selected McKesson to distribute Vivagel, it might be for sale in the US right now.

As for Viraleze, the US consumer may not "give a stuff" about a nasal spray unproven outside of the lab. The pandemic panic is subsiding here. Vaccinations are going so well in the US that some parts of the country may already have herd immunity. Most of the country may be there by the end of April.

As a long-term SPL shareholder (via ADR), I am very interested in Viraleze sales in the UK and Europe. But given SPL's usual reporting practices, we may not have useful sales info for several months. And regardless of units sold, we may be forced to estimate (guess at?) the net profits.